Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.

NCT02558114 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitment

Conditions

Hepatitis E

Interventions

DRUG: Ribavirin

Sponsor

Hospital Universitari Vall d'Hebron Research Institute